about
A reversible model of the cognitive impairment associated with schizophrenia in monkeys: potential therapeutic effects of two nicotinic acetylcholine receptor agonists.Synaptic plasticity, neural circuits, and the emerging role of altered short-term information processing in schizophrenia.The global cognitive impairment in schizophrenia: consistent over decades and around the worldPsychological flexibility as a fundamental aspect of healthElectrophysiological, cognitive and clinical profiles of at-risk mental state: The longitudinal Minds in Transition (MinT) study.Nicotine, Auditory Sensory Memory, and sustained Attention in a Human Ketamine Model of Schizophrenia: Moderating Influence of a Hallucinatory Trait.Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early--and additional memory dysfunction in the late--prodromal stateContribution of nonprimate animal models in understanding the etiology of schizophrenia.Molecular targets for treating cognitive dysfunction in schizophrenia.Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?Imaging genetic liability to schizophrenia: systematic review of FMRI studies of patients' nonpsychotic relatives.Neurological soft signs and their relationships to neurocognitive functions: a re-visit with the structural equation modeling design.Color Stroop and negative priming in schizophrenia: an fMRI studyNeurocognitive Decrements are Present in Intellectually Superior Schizophrenia.Comparing prefrontal gray and white matter contributions to intelligence and decision making in schizophrenia and healthy controls.Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in Schizophrenia.Premorbid cognitive deficits in young relatives of schizophrenia patients.Neuropsychiatric aspects of schizophrenia.A reappraisal of the association between Dysbindin (DTNBP1) and schizophrenia in a large combined case-control and family-based sample of German ancestryNeurocognitive decline in early-onset schizophrenia compared with ADHD and normal controls: evidence from a 13-year follow-up study.White matter tract abnormalities between rostral middle frontal gyrus, inferior frontal gyrus and striatum in first-episode schizophrenia.Pergolide treatment of cognitive deficits associated with schizotypal personality disorder: continued evidence of the importance of the dopamine system in the schizophrenia spectrum.Neurological soft signs in schizophrenia: a meta-analysis.The effects of risperidone on the cognitive performance of individuals with schizotypal personality disorder.Context processing in schizotypal personality disorder: evidence of specificity of impairment to the schizophrenia spectrum.Cariprazine, a new, orally active dopamine D2/3 receptor partial agonist for the treatment of schizophrenia, bipolar mania and depression.Multivariate neuroanatomical classification of cognitive subtypes in schizophrenia: a support vector machine learning approach.Subtyping schizophrenia: implications for genetic research.Reduction in perseverative errors with adjunctive ethyl-eicosapentaenoic acid in patients with schizophrenia: Preliminary studyNeuropsychology of reward learning and negative symptoms in schizophreniaDiabetes and cognitive deficits in chronic schizophrenia: a case-control study.Age of onset of schizophrenia: perspectives from structural neuroimaging studiesPro-cognitive and antipsychotic efficacy of the alpha7 nicotinic partial agonist SSR180711 in pharmacological and neurodevelopmental latent inhibition models of schizophrenia.Notes from Underground: Are Cognitive-Enhancing Drugs Respecting their Promises?Mistreating Psychology in the Decades of the BrainThe diagnostic concept of schizophrenia: its history, evolution, and future prospects.New visual information processing abnormality biomarker for the diagnosis of SchizophreniaPsychoeducation for patients with a psychotic disorder: effects on knowledge and coping.Spatial attentional control is not impaired in schizophrenia: Dissociating specific deficits from generalized impairments.Primate phencyclidine model of schizophrenia: sex-specific effects on cognition, brain derived neurotrophic factor, spine synapses, and dopamine turnover in prefrontal cortex.
P2860
Q24650678-DE58AF2D-0264-4386-AFC0-68C1A30D72AAQ26829347-3C3919D8-2142-47C9-AC7F-A3C2464BAB9DQ27000334-91CF08BA-541A-4CE7-B0D2-319721D845BFQ28300705-535298CC-97FE-4BC5-923A-6FCE6C33497BQ30362549-BDF8C7F9-3485-42BB-9951-63023A15301AQ30462575-AE7BA66A-ED8B-4FE1-AEA6-4CBFD4604AAAQ30466264-46ABDA73-59C5-4E51-9A1A-141D74EED297Q30474963-AE0B2988-F00B-4A1C-83BC-A90AE6029EC7Q30491310-A52CB1C4-CD50-4DF0-8E96-F04CD4A5F4A5Q31095554-82B0340B-1A62-42C7-BBC2-FAABF411012EQ31159319-7857CF38-1C33-439D-8D67-28A92BAABE38Q33521197-4B3F9A98-1C47-45EA-ADA6-7124BF2D782FQ33589403-F8D3754A-D38B-468B-BB2C-15D1ADEC993CQ33606029-BC23650D-CFA3-47AE-A225-15F1B5DC721AQ33623842-C553EC9B-6A2B-4385-A38D-5D380D8CAD0DQ33707711-98294302-DFEF-4912-89EC-E44DE4621703Q33731772-5051677D-310F-4511-A6F4-93ACC08C3C88Q33784014-69635FBB-0214-4FA1-A7BE-64E721285F77Q33798551-CD3281A3-749C-45E8-843B-46DC79696AC1Q33890155-12978F79-FBFE-4A19-96B7-F9A3D61AE272Q33949733-5EF18851-9C86-4A62-8A41-DC4EFE9DEE61Q34096784-362EB23B-8EC2-46F5-90BF-D9BA55F35496Q34235412-48873BF2-4F2F-4173-8D2A-E05BF8BD8CA1Q34252311-065FDD07-C27C-4089-AA28-CC9F10F6E7F0Q34252367-7B9BF5A4-A7A5-4D50-8BBC-D7248EA990FFQ34381557-E1303636-A83A-47B5-B183-3D5545ACA9B8Q34432031-E33022BA-2328-46A6-85E3-DB257F4A4D3CQ34542103-8A0239AB-6BE2-4C09-B93C-401528E9D9FEQ34550685-1E394CB5-9AE7-45C3-9801-0205258F810DQ34620858-A1E9BF0D-4B3A-41F1-849F-2E1E877E4A75Q34805258-D25CA8AF-9FFC-4E1B-85CE-1575B9722046Q34830454-19FBB5B1-69DC-4019-8D8B-1113D80AB5DBQ34926526-B96880DD-66B6-4F6D-BC69-2111800C505FQ35157252-1FB9FC49-3D9A-40DF-8EEC-BA3A84B673F2Q35224964-5ECEA6D0-8066-4FD6-AD29-40BF8A323C8BQ35237275-A04A7E78-9752-4067-A4FC-5328ADAC2A0FQ35321513-E0862604-C79A-4121-B643-AE7C2EEF85BCQ35559899-17CF3B40-104D-47AA-B383-5A4C63D50CAAQ35598059-C3A71664-AB94-48A8-8773-B97F1A71C27CQ35626908-280A811F-8680-460B-A74F-66EF16219379
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The primacy of cognition in schizophrenia.
@ast
The primacy of cognition in schizophrenia.
@en
type
label
The primacy of cognition in schizophrenia.
@ast
The primacy of cognition in schizophrenia.
@en
prefLabel
The primacy of cognition in schizophrenia.
@ast
The primacy of cognition in schizophrenia.
@en
P1476
The primacy of cognition in schizophrenia.
@en
P2093
R Walter Heinrichs
P304
P356
10.1037/0003-066X.60.3.229
P577
2005-04-01T00:00:00Z